591 related articles for article (PubMed ID: 16505657)
1. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
[TBL] [Abstract][Full Text] [Related]
2. Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
Samuels J; Finkel K; Gubert M; Johnson T; Shaw A
Ren Fail; 2005; 27(1):101-5. PubMed ID: 15717642
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review.
Moffett BS; Mott AR; Nelson DP; Goldstein SL; Jefferies JL
Pediatr Crit Care Med; 2008 Jul; 9(4):403-6. PubMed ID: 18496409
[TBL] [Abstract][Full Text] [Related]
4. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery.
Roasio A; Lobreglio R; Santin A; Landoni G; Verdecchia C
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):23-6. PubMed ID: 18249326
[TBL] [Abstract][Full Text] [Related]
5. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine?
Duke GJ; Briedis JH; Weaver RA
Crit Care Med; 1994 Dec; 22(12):1919-25. PubMed ID: 7988127
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
Barr LF; Kolodner K
Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903
[TBL] [Abstract][Full Text] [Related]
7. Fenoldopam: renal-dose dopamine redux?
Murray PT
Crit Care Med; 2006 Mar; 34(3):910-1. PubMed ID: 16505681
[No Abstract] [Full Text] [Related]
8. Fenoldopam in critically ill patients with early renal dysfunction. A crossover study.
Cobas M; Paparcuri G; De La Pena M; Cudemus G; Barquist E; Varon A
Cardiovasc Ther; 2011 Aug; 29(4):280-4. PubMed ID: 20955210
[TBL] [Abstract][Full Text] [Related]
9. Dopamine "renal dose" versus fenoldopam mesylate to prevent ischemia-reperfusion injury in renal transplantation.
Fontana I; Germi MR; Beatini M; Fontana S; Bertocchi M; Porcile E; Saltalamacchia L; Ornis S; Ghinolfi D; Bonifazio L; Valente U
Transplant Proc; 2005; 37(6):2474-5. PubMed ID: 16182714
[TBL] [Abstract][Full Text] [Related]
10. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial.
Bove T; Landoni G; Calabrò MG; Aletti G; Marino G; Cerchierini E; Crescenzi G; Zangrillo A
Circulation; 2005 Jun; 111(24):3230-5. PubMed ID: 15967861
[TBL] [Abstract][Full Text] [Related]
11. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
Ranucci M; Soro G; Barzaghi N; Locatelli A; Giordano G; Vavassori A; Manzato A; Melchiorri C; Bove T; Juliano G; Uslenghi MF
Ann Thorac Surg; 2004 Oct; 78(4):1332-7; discussion 1337-8. PubMed ID: 15464494
[TBL] [Abstract][Full Text] [Related]
12. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial.
van der Voort PH; Boerma EC; Koopmans M; Zandberg M; de Ruiter J; Gerritsen RT; Egbers PH; Kingma WP; Kuiper MA
Crit Care Med; 2009 Feb; 37(2):533-8. PubMed ID: 19114909
[TBL] [Abstract][Full Text] [Related]
13. A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction.
Garwood S; Swamidoss CP; Davis EA; Samson L; Hines RL
J Cardiothorac Vasc Anesth; 2003 Feb; 17(1):17-21. PubMed ID: 12635055
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
15. Effect of N-acetyl-cysteine (NAC) added to fenoldopam or dopamine on end-tidal carbon dioxide and mean arterial pressure at time of renal artery declamping during cadaveric kidney transplantation.
Sorbello M; Morello G; Parrinello L; Molino C; Rinzivillo D; Pappalardo R; Cutuli M; Corona D; Veroux P; Veroux M
Transplant Proc; 2010 May; 42(4):1056-60. PubMed ID: 20534223
[TBL] [Abstract][Full Text] [Related]
16. Acute kidney injury criteria predict outcomes of critically ill patients.
Barrantes F; Tian J; Vazquez R; Amoateng-Adjepong Y; Manthous CA
Crit Care Med; 2008 May; 36(5):1397-403. PubMed ID: 18434915
[TBL] [Abstract][Full Text] [Related]
17. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency.
Hans SS; Hans BA; Dhillon R; Dmuchowski C; Glover J
Am Surg; 1998 May; 64(5):432-6. PubMed ID: 9585778
[TBL] [Abstract][Full Text] [Related]
18. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
[TBL] [Abstract][Full Text] [Related]
19. Fenoldopam vs dopamine as a nephroprotective strategy during living donor kidney transplantation: preliminary data.
Sorbello M; Morello G; Paratore A; Cutuli M; Mistretta G; Belluoccio AA; Veroux M; Veroux P; Macarone M; Gagliano M; Mangianeli S
Transplant Proc; 2007; 39(6):1794-6. PubMed ID: 17692615
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?
Priglinger U; Delle Karth G; Geppert A; Joukhadar C; Graf S; Berger R; Hülsmann M; Spitzauer S; Pabinger I; Heinz G
Crit Care Med; 2003 May; 31(5):1405-9. PubMed ID: 12771610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
